You must log in or register to comment.
In 8 of 16 patients studied, the vaccines activated T cells that recognize the patient’s own pancreatic cancers. These patients also showed delayed recurrence of their pancreatic cancers, suggesting the T cells activated by the vaccines may be having the desired effect to keep pancreatic cancers in check.
Good news, but the headline lacks nuance.
Blatant skepticism replaced with cautious optimism